Literature DB >> 16429402

Functional assays testing pathogenicity of 14 cystathionine-beta synthase mutations.

Roser Urreizti1, Carla Asteggiano, Mónica Cozar, Nina Frank, María Antonia Vilaseca, Daniel Grinberg, Susana Balcells.   

Abstract

In this study, 14 CBS alleles from homocystinuric patients were expressed heterologously in E. coli and their enzyme activities were assayed in vitro. Additionally, mutant CBS proteins were visualized by Western blot from denaturing and non-denaturing polyacrylamide gels. The 14 mutations characterized were: p.R125W (c.373C>T), p.G148R (c.442G>A), p.M173V (c.517A>G), p.T191M (c.572C>T), p.A226T (c.676G>A), p.C275Y (c.824G>A), p.R336C (c.1006C>T), p.R336H (c.1007G>A), p.L338P (c.1013T>C), p.S349N (c.1046G>A), p.R379Q (c.1136G>A), p.L456P (c.1367T>C), p.G522fsX540 (c.1566delG), and p.R548Q (c.1643G>A). Eleven of the mutant alleles exhibited an activity lower than 4% of the wild-type protein. In contrast, mutations p.A226T and p.M173V presented 20% and 40% of the wild-type activity, respectively, whereas the activity of p.R548Q was up to 60% of the wild-type. This suggests that it is a new rare variant rather than a pathogenic mutation. Most of the mutated proteins exhibited a decreased signal in Western blot analyses. The non-denaturing PAGE revealed that the wild-type protein retained the capacity to form a multimeric quaternary structure, whereas in the mutations p.M173V, p.A226T, and p.G548Q, this structure grade was dramatically reduced and was completely absent in the rest of the mutations. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16429402     DOI: 10.1002/humu.9395

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Surrogate genetics and metabolic profiling for characterization of human disease alleles.

Authors:  Jacob A Mayfield; Meara W Davies; Dago Dimster-Denk; Nick Pleskac; Sean McCarthy; Elizabeth A Boydston; Logan Fink; Xin Xin Lin; Ankur S Narain; Michael Meighan; Jasper Rine
Journal:  Genetics       Date:  2012-01-20       Impact factor: 4.562

2.  Neurodevelopmental and Cognitive Outcomes of Classical Homocystinuria: Experience from Qatar.

Authors:  Haitham El Bashir; Lubna Dekair; Yasmeen Mahmoud; Tawfeg Ben-Omran
Journal:  JIMD Rep       Date:  2015-02-25

3.  Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity.

Authors:  Viktor Kozich; Jitka Sokolová; Veronika Klatovská; Jakub Krijt; Miroslav Janosík; Karel Jelínek; Jan P Kraus
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

4.  The p.T191M mutation of the CBS gene is highly prevalent among homocystinuric patients from Spain, Portugal and South America.

Authors:  Roser Urreizti; Carla Asteggiano; Marta Bermudez; Alfonso Córdoba; Mariana Szlago; Carola Grosso; Raquel Dodelson de Kremer; Laura Vilarinho; Vania D'Almeida; Mercedes Martínez-Pardo; Luís Peña-Quintana; Jaime Dalmau; Jaime Bernal; Ignacio Briceño; María Luz Couce; Marga Rodés; Maria Antonia Vilaseca; Susana Balcells; Daniel Grinberg
Journal:  J Hum Genet       Date:  2006-02-15       Impact factor: 3.172

5.  Reduced response of Cystathionine Beta-Synthase (CBS) to S-Adenosylmethionine (SAM): Identification and functional analysis of CBS gene mutations in Homocystinuria patients.

Authors:  Marisa I S Mendes; Henrique G Colaço; Desirée E C Smith; Rúben J J F Ramos; Ana Pop; Silvy J M van Dooren; Isabel Tavares de Almeida; Leo A J Kluijtmans; Mirian C H Janssen; Isabel Rivera; Gajja S Salomons; Paula Leandro; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2013-08-23       Impact factor: 4.982

6.  Cross-talk between the catalytic core and the regulatory domain in cystathionine β-synthase: study by differential covalent labeling and computational modeling.

Authors:  Ales Hnízda; Vojtech Spiwok; Vojtech Jurga; Viktor Kozich; Milan Kodícek; Jan P Kraus
Journal:  Biochemistry       Date:  2010-11-17       Impact factor: 3.162

7.  A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase.

Authors:  Song Sun; Jochen Weile; Marta Verby; Yingzhou Wu; Yang Wang; Atina G Cote; Iosifina Fotiadou; Julia Kitaygorodsky; Marc Vidal; Jasper Rine; Pavel Ješina; Viktor Kožich; Frederick P Roth
Journal:  Genome Med       Date:  2020-01-30       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.